After TikTok’s CEO endured a bipartisan grilling in a House hearing, some analysts say a prohibition is still unlikely. Others disagree.

Emergent BioSolutions stock gains after FDA approves the company’s opioid overdose-reversing nasal spray, Narcan, for over-the-counter sales.

A new ‘true cost of pet parenthood’ report finds people paying hundreds, if not thousands, to take care of their fur babies each year. Inflation doesn’t help.

People are likely to turn to short-form video alternatives from Meta Platforms Inc. (Reels), Alphabet Inc.’s YouTube (Shorts) and Snap Inc. (Spotlight), Morgan Stanley said.

The Dutch city is trying to clean up its tourists by asking young British males to behave better or just don’t come.

The implosion of Silicon Valley Bank exacerbates cracks in venture funding that could lead to dark days for some startups and a rise in so-called “zombie VCs”

The authors of ‘Cars and Jails’ were surprised to learn the role that cars play in the nation’s carceral system.  

Micron’s latest earnings brought a massive inventory write-down, its largest quarterly loss on record and continued questions about when the bottom will appear.

U.S. pending-home sales rose 0.8% in February, the National Association of Realtors said on Wednesday.

Lawsuit is narrowed to the Finger Lakes region, while the state will issue licenses for the Western, Central, Mid-Hudson and Brooklyn regions.